Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis

INTRODUCTION: Plasmacytoid variant bladder cancer is a rare variant of urothelial carcinoma that accounts for 1% of bladder cancers. Plasmacytoid variant urothelial carcinoma is characterized by an aggressive phenotype and poor clinical outcomes. CASE PRESENTATION: A 61‐year‐old woman presented with...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Yusuke, Tanaka, Satoki, Maruo, Masafumi, Sugawara, Sho, Chiba, Kazuto, Miyazaki, Kanetaka, Inoue, Atsushi, Ichikawa, Tomohiko, Nagata, Maki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249653/
https://www.ncbi.nlm.nih.gov/pubmed/35795120
http://dx.doi.org/10.1002/iju5.12463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249653/
https://www.ncbi.nlm.nih.gov/pubmed/35795120
http://dx.doi.org/10.1002/iju5.12463

Ejemplares similares